Ausgabe 3/2022
Inhalt (11 Artikel)
Leading Article
Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Arteries: Current Gaps and Future Directions
Islam Y. Elgendy, Lina Ya’Qoub, Kuan-Han Chen, Carl J. Pepine
Open Access
Review Article
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, Lindsay R. Meredith, Brian Hurley, Karen Miotto, Artha J. Gillis, Lara A. Ray
Open Access
Review Article
Pharmacologic Management of Persistent Pain in Cancer Survivors
Paul Glare, Karin Aubrey, Amitabh Gulati, Yi Ching Lee, Natalie Moryl, Sarah Overton
Systematic Review
Statins and Gliomas: A Systematic Review of the Preclinical Studies and Meta-Analysis of the Clinical Literature
Luis F. Rendon, Ishaan A. Tewarie, David J. Cote, Aaron Gabriel, Timothy R. Smith, Marike L. D. Broekman, Rania A. Mekary
Original Research Article
Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases
Tian Li, Rui Providencia, Wenhua Jiang, Manling Liu, Lu Yu, Chunhu Gu, Alex Chia Yu Chang, Heng Ma
Letter to the Editor
Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
Mario Gennaro Mazza, Benedetta Vai, Livia De Picker, Francesco Benedetti, Raffaella Zanardi
Letter to the Editor
Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”
Eric J. Lenze, Angela M. Reiersen, Shelley N. Facente
Correction
Correction to: Ocular Toxicity of Targeted Anticancer Agents
Blake H. Fortes, Prashant D. Tailor, Lauren A. Dalvin